<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>777</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11556718</PubmedId>
            <Abstract>Epitopes on envelope glycoprotein of Indian strain of Japanese encephalitis virus were delineated by prediction methods. Monoclonal antibodies (MAb) raised against a putative B cell epitope peptide, reacted with the virion in ELISA and immunofluorescence assays. One MAb was also able to neutralize the virus. The reactivity of this MAb against a Sri Lankan strain was checked, since this strain had a substitution within the B cell epitope at position Egp 153 (G--&gt;W). The MAb was able to bind to, but was not able to neutralize the Sri Lankan isolate. The data indicated that the predicted B cell epitope is a neutralizing epitope and may be included in a peptide-based vaccine against the virus.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>1427-35</ArticlePages>
            <ArticleTitle>Monoclonal antibody raised against envelope glycoprotein peptide neutralizes Japanese encephalitis virus.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Dewasthaly</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Ayachit</LastName>
                    <ForeName>V M</ForeName>
                </Author>
                <Author>
                    <LastName>Sarthi</LastName>
                    <ForeName>S A</ForeName>
                </Author>
                <Author>
                    <LastName>Gore</LastName>
                    <ForeName>M M</ForeName>
                </Author>
            </Authors>
            <Affiliations>National Institute of Virology, Pune, India.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Viral;Antigens, Viral;Epitopes;Peptides;Vaccines, Synthetic;Viral Envelope Proteins;Viral Vaccines</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(immunology); Antibodies, Viral(immunology); Antigens, Viral(immunology); B-Lymphocytes(immunology); Cross Reactions; Dose-Response Relationship, Immunologic; Encephalitis Virus, Japanese(immunology); Encephalitis, Japanese(prevention &amp; control); Epitopes(immunology); Humans; Mice; Mice, Inbred BALB C; Peptides(immunology); Sri Lanka; Vaccines, Synthetic; Viral Envelope Proteins(immunology); Viral Vaccines(chemistry; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>146</Volume>
                <Issue>7</Issue>
                <Title>Archives of virology</Title>
                <Issn>0304-8608</Issn>
                <MedlineTa>Arch Virol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Egp 149-163</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SENHGNYSAQVGASQ</LinearSequence>
                        <StartingPosition>149</StartingPosition>
                        <EndingPosition>163</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAB51520.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11076</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 1428</LocationOfData>
                <EpitopeId>57569</EpitopeId>
                <ReferenceStartingPosition>149</ReferenceStartingPosition>
                <ReferenceEndingPosition>163</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>The strain used is actually a Indian strain (Bankura) very similar to NAlso known asyama strain.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3B</LocationOfData>
                        <BCellId>8132</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SENHGNYSAQVGASQ</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAB51520.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11076</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Egp 149-163</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>NP_990483.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>9031</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>First dose in CFA, 2 weekly boosts in IFA. Splenocytes where fused with cell line Sp/2/0 for mAb production.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>62.5</ResponseFrequency>
                            <AssayComments>Peptide specific mAb prevents mortality when preincubated with JEV virus from source strain, while in vivo protection with Sri Lanka strain is not achieved, possibly due to a point mutation (G153W).</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>IC10F6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11076</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>8131</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SENHGNYSAQVGASQ</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAB51520.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11076</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Egp 149-163</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>NP_990483.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>9031</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>First dose in CFA, 2 weekly boosts in IFA. Splenocytes where fused with cell line Sp/2/0 for mAb production.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>38</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Peptide specific mAb is able to recognize antigen in cells infected with source species (Bankura Strain) in both fixed and non-fixed (surface exposed antigen) samples. Cells infected with Sri Lanka strain are also recognized.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>IC10F6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11076</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>8130</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SENHGNYSAQVGASQ</LinearSequence>
                                            <StartingPosition>149</StartingPosition>
                                            <EndingPosition>163</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAB51520.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11076</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Egp 149-163</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <GenBankId>NP_990483.1</GenBankId>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>9031</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>First dose in CFA, 2 weekly boosts in IFA. Splenocytes where fused with cell line Sp/2/0 for mAb production.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Peptide specific mAb is able to recognize the source species.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>IC10F6</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgM</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Japanese Encephalitis virus (JEV)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11076</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

